Literature DB >> 10027315

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis.

M Sawada1, S Miyake, S Ohdama, O Matsubara, S Masuda, K Yakumaru, Y Yoshizawa.   

Abstract

Tissue factor (TF) is an initiator of the extrinsic cascade of blood coagulation. Although recent studies have revealed a relationship between metastatic properties and TF expression in some neoplastic cells, the significance of TF in lung cancer, especially in non-small-cell lung cancer (NSCLC), is still unclear. In this study, TF was detected in NSCLC cell lines by functional study, Western blot analysis and immunocytochemical staining. TF levels in eight NSCLC cell lines were also quantitated by enzyme-linked immunosorbent assay (ELISA), and TF expression was evaluated in 55 specimens of surgically resected NSCLCs. NSCLC cell lines derived from metastatic lesions produced high levels of TF (48.3+/-23.5 ng 10(-6) cells, mean +/- s.e.m.), whereas those derived from primary lesions produced low levels of TF (0.2+/-0.1 ng 10(-6) cells). Immunohistochemical studies disclosed significantly stronger staining for TF in cells from NSCLC patients with metastasis than in those without metastasis. Among the 28 patients with metastasis, ten were strongly positive, 16 were moderately positive and two were negative for TF. In contrast, among the 27 patients without metastasis, only two were strongly positive, 18 were moderately positive and seven were negative for TF. Therefore, malignant cells from patients with lung cancer produce various levels of TF, and TF may play an important role in the metastatic process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027315      PMCID: PMC2362438          DOI: 10.1038/sj.bjc.6690073

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

2.  Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells.

Authors:  Y Gunji; E Gorelik
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

3.  Antibody mapping of tissue factor implicates two different exon-encoded regions in function.

Authors:  W Ruf; A Rehemtulla; T S Edgington
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

4.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

Authors:  J N Wilcox; K M Smith; S M Schwartz; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Immunohistochemical identification of tissue factor in solid tumors.

Authors:  N S Callander; N Varki; L V Rao
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

6.  Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.

Authors:  N Esumi; D Fan; I J Fidler
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

7.  Establishment of a new human cancer cell line secreting protease nexin-II/amyloid beta protein precursor derived from squamous-cell carcinoma of lung.

Authors:  H Itoh; H Kataoka; H Koita; K Nabeshima; T Inoue; K Kangawa; M Koono
Journal:  Int J Cancer       Date:  1991-09-30       Impact factor: 7.396

8.  Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.

Authors:  D L Ornstein; L R Zacharski; V A Memoli; W Kisiel; B J Kudryk; J Hunt; S M Rousseau; D C Stump
Journal:  Cancer       Date:  1991-09-01       Impact factor: 6.860

9.  Cell line A549: a model system for the study of alveolar type II cell function.

Authors:  B T Smith
Journal:  Am Rev Respir Dis       Date:  1977-02

10.  Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.

Authors:  A S Adamson; P Luckert; M Pollard; M E Snell; M Amirkhosravi; J L Francis
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more
  22 in total

1.  Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma.

Authors:  Andreia Da Silva de Oliveira; Luize G Lima; Andréa Mariano-Oliveira; Daniel E Machado; Luiz E Nasciutti; John F Andersen; Lars C Petersen; Ivo M B Francischetti; Robson Q Monteiro
Journal:  Thromb Res       Date:  2012-06-09       Impact factor: 3.944

2.  MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells.

Authors:  Xiaoxi Zhang; Haijun Yu; Jessica R Lou; Jie Zheng; Hua Zhu; Narcis-Ioan Popescu; Florea Lupu; Stuart E Lind; Wei-Qun Ding
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

3.  Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.

Authors:  Stephan L Haas; Ralf Jesnowski; Michael Steiner; Frank Hummel; Jörg Ringel; Christine Burstein; Horst Nizze; Stefan Liebe; J Matthias Löhr
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

4.  Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.

Authors:  Nicole Hahn; Margarethe Heiden; Rainer Seitz; Ursula Salge-Bartels
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

Review 5.  Tissue factor: a neglected role in cancer biology.

Authors:  Haiyuan Li; Yang Yu; Lei Gao; Peng Zheng; Xiaolong Liu; Hao Chen
Journal:  J Thromb Thrombolysis       Date:  2022-06-28       Impact factor: 2.300

6.  Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma.

Authors:  T Sato; I Tsujino; D Ikeda; M Ieko; M Nishimura
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 7.  Regulating surgical oncotaxis to improve the outcomes in cancer patients.

Authors:  Toshihiro Hirai; Hideo Matsumoto; Hisako Kubota; Yoshiyuki Yamaguchi
Journal:  Surg Today       Date:  2013-06-05       Impact factor: 2.549

8.  Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer.

Authors:  Jo-Chi Tseng; Liang-Che Chang; Boy-Yiing Jiang; Yu-Chih Liu; Hung-Jie Chen; Chih-Teng Yu; Chung-Ching Hua
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-30       Impact factor: 4.553

9.  Tissue factor associates with survival and regulates tumour progression in osteosarcoma.

Authors:  Chris Tieken; Michiel C Verboom; Wolfram Ruf; Hans Gelderblom; Judith V M G Bovée; Pieter H Reitsma; Anne-Marie Cleton-Jansen; Henri H Versteeg
Journal:  Thromb Haemost       Date:  2016-01-14       Impact factor: 5.249

10.  Fed-batch culture optimization of a growth-associated hybridoma cell line in chemically defined protein-free media.

Authors:  Xianghui Gong; Dongxiao Li; Xuesen Li; Qiangyi Fang; Xiangzong Han; Yuyin Wu; Shengli Yang; Bing Q Shen
Journal:  Cytotechnology       Date:  2006-12-02       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.